Silver Spring, Md.-based United Therapeutics Corp. and the FDA are duking it out in court over whether the agency improperly denied the biotechnology company seven years of orphan drug exclusivity for its drug Orenitram.
{iframe}https://www.bna.com/hey-dude-wheres-b73014473756/{/iframe}